CuraScientific Past Earnings Performance
Past criteria checks 2/6
There is insufficient data on CuraScientific's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | 1,552.4% |
| Return on equity | n/a |
| Net Margin | 3,201.8% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How CuraScientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 1 | 34 | 2 | 0 |
| 30 Jun 23 | 1 | 40 | 2 | 0 |
| 31 Mar 23 | 0 | -1 | 1 | 0 |
| 31 Dec 22 | 0 | -5 | 2 | 0 |
| 30 Sep 22 | 0 | -5 | 2 | 0 |
| 30 Jun 22 | 0 | -6 | 1 | 0 |
| 31 Mar 22 | 0 | -11 | 4 | 0 |
| 31 Dec 21 | 0 | -6 | 4 | 0 |
| 30 Sep 21 | 0 | -4 | 0 | 0 |
| 31 Mar 21 | 0 | 0 | -2 | 0 |
| 31 Dec 20 | 0 | -5 | 2 | 0 |
| 31 Dec 19 | 0 | 0 | 0 | 0 |
Quality Earnings: CSTF has high quality earnings.
Growing Profit Margin: CSTF became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if CSTF's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: CSTF has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CSTF has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (4.8%).
Return on Equity
High ROE: CSTF's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.